patients who undergo surgery for brain tumours helps to guide surgery, reduce recurrence and minimize morbidity. This study validated a 25-item, modified QoL questionnaire based on the Medical Outcomes Survey SF-36 and the Karnofsky Performance Scale. The aims were for it to be brain tumour specific for Chinese patients, hence more sensitive, more acceptable, briefer and more easily used. A total of 431 patients with brain tumours were compared with 96 age-matched healthy controls. A surgery-related QoL curve was used to help identify a threshold satisfaction point for QoL. Physiological function, psychological function, satisfaction with medical care and self-care ability of the patients were compared pre-operatively and post-operatively. Cronbach's ␣-coefficient was 0.9521 and the correlation coefficient was 0.8685, suggesting good reliability and repeatability. With the exception of psychological function, which deteriorated, the modified QoL showed significant improvement in physiological function, satisfaction with medical care and self-care ability, and serves to stress the importance of post-operative psychological support.
Introduction
For many years, success or failure in medicine have been judged using purely academic medical criteria, however this does not satisfy patients or their relatives in today's society. To achieve satisfaction, new parameters for measuring the success of some invasive and costly procedures need to be included. 1 -3 One of these parameters is quality of life (QoL). This term appears with increasing frequency in medicine but, at the moment, there are no standardized and universally acknowledged methods of measurement. 4, 5 Although QoL is a concept that has defied a universally agreed definition, the concept of health-related QoL (HRQL) is narrower, and can be pragmatically defined as a patient's perception and Y Miao, Y Qiu, Y Lin et al. Health-related QoL in patients with brain tumours evaluation of the effects of an illness and its treatment on his/her life and sense of wellbeing. For practical purposes the ideas of Aaronson et al. 6 should be considered, whereby quality of life is an abstract concept which has to be divided into its component parts before any effective measurement can take place. Such a measuring device needs to be multidimensional and must contain at least four categories: physical complaints (i.e. somatic emotions, symptoms), psychological distress (i.e. anxiety, depression), social interactions (i.e. quality and quantity of relationships with others) and functional status (i.e. activity level, professional activity).
Very little literature can be found on the QoL of patients with brain tumours and on neurosurgical patients in general. 7, 8 Gliomas, meningiomas and pituitary adenomas are common central nerve system tumours, for which surgical excision is the first choice of treatment. Due to the complexity of brain tumour surgery, the prediction and measurement of QoL in brain tumour patients who undergo surgery is difficult but, nevertheless, very important and necessary. 9 -13 Since survival rates for brain tumours have increased substantially in the past 30 years in North America and western Europe, increasing attention has been focused on the burdens of morbidity associated with the short-and long-term effects of treatment. 14 Measurements of health status and HRQL can make useful contributions in this regard. 15, 16 As survival rates for brain cancer patients improve also in China, 17, 18 measurement of comprehensive health status and HRQL in patients in these areas also becomes increasingly important.
A suitable questionnaire can make the QoL research much more reliable. Many questionnaires designed by western scientists, such as the Medical Outcomes Survey SF-36, the Health Utilities Index (HUI) and the Karnofsky Performance Scale (KPS), have been adapted to the study of patients in China; however, questionnaires concerning brain tumour related QoL remain unchanged. Generic QoL measures may be relatively insensitive to brain tumours and their therapies, so their use is not optimal. There may also be QoL issues that are affected by cultural differences that exist between China and other countries, for example the financial burden of medicine, that inject uncertainty into the results of generic QoL measures. To minimize this uncertainty, a modified questionnaire based on the Medical Outcomes Survey SF-36 and the KPS was designed.
The main objectives of the present study were to assess the validity and reliability of the modified QoL questionnaire, designed specifically for Chinese patients with brain tumours, and to investigate the comprehensive health status and QoL of survivors from their own perspectives. The QoL of survivors of brain tumours in China was also compared with the general population.
Patients and methods

PATIENTS
Patients who underwent brain tumour surgery in the Department of Neurosurgery at Ren Ji Hospital, Shanghai, China (affiliated with Shanghai Jiao Tong University School of Medicine) and Wuxi Second Hospital, Wuxi, China (affiliated with Nanjing Medical University) between January 2002 and December 2004 were consecutively enrolled in this study. In order to be eligible, patients were required to have integrated medical records, be able to answer questionnaires post-operatively and give informed consent to participate. This study Y Miao, Y Qiu, Y Lin et al. Health-related QoL in patients with brain tumours was approved by the ethics review committees of both hospitals.
Age-matched controls (both students and teachers) were recruited from Shanghai Jiao Tong University School of Medicine and their consent to participate in the study was also obtained.
DEVELOPMENT OF THE QUESTIONNAIRE
Twenty-five QoL indexes were selected based on the standard QoL questionnaires of the Medical Outcomes Survey SF-36 and KPS, and in consultation with neurologists and experts in public health and oncology. Of the QoL indexes, 10 represented physiological aspects, eight represented psychological aspects, two represented patient satisfaction with medical care and five were selected to assess self-care ability, especially the activities of daily living (Table 1) . Singleattribute and QoL utility scores for each patient were generated by the respective modified questionnaire utility functions. The utility scores had interval-scale properties and represented community preferences. Single-attribute, or within dimension, scores for the first 20 indexes (physiological, psychological and patient satisfaction) were measured on the following 0 -4 scale: extremely severe, 0; severe, 1; moderate, 2; mild, 3; and none, 4. Scores for the activities of daily living were measured on the following scale: independent, 0; somewhat dependent on help 2; and totally dependent on help, 4. Thus the maximum score overall was 100.
ASSESSMENT OF THE QUESTIONNAIRE
Self assessment is considered the gold standard for describing the health of study subjects. The questionnaire that was developed was, therefore, tested on patients with brain tumours and age-matched controls. Follow-up was performed through face-to-face interviews.
The sensitivity and specificity of the modified questionnaire were determined from logistic regression data of the results Scores for the activities of daily living (self-care) were measured on the following scale: independent, 0; somewhat dependent on help 2; and totally dependent on help, 4. Health-related QoL in patients with brain tumours and a receiver operating characteristics (ROC) curve was compiled. This is a graphical representation of the trade off between the positive and negative predictive values for every possible cut off, and shows the true-positive rate (i.e. sensitivity; y-axis) versus the false-positive rate (i.e. 1specificity; x-axis). The ROC curve would enable evaluation of how well the questionnaire performed in classifying a person whose condition is known. The accuracy of the assessment was measured by the area under the ROC curve.
STATISTICAL ANALYSIS
All the data were analysed using the Statistical Package for the Social Sciences (SPSS ® ) version 13.0 (SPSS Inc. Chicago, IL, USA). Mean interrater differences across subjects were assessed by paired t-tests. Frequency distributions summarized categorical-scale data and differences in proportions were assessed using the χ 2 test. Summary statistics were used to describe the distributions of interval-scale variables. Differences in mean scores between study groups were assessed using the t-test for independent groups. Correlation analysis and Cronbach's α-coefficient analysis were used to analyse reliability and validity of the questionnaire. The level of statistical significance was set at P < 0.05. All the statistical work and all interviews were performed by the first author (Y.M.). Statistical analysis was performed on all 431 of the brain tumour participants. Imaging evaluation of brain tumours was carried out by computed tomography or magnetic resonance imaging. Histological grading was according to the World Health Organization's classification. 19 
Results
PARTICIPANTS
RELIABILITY AND VALIDITY OF THE QOL QUESTIONNAIRE
Cronbach's α-coefficient was 0.9521, which indicates that the questionnaire has good reliability and validity. In addition, 84 patients were tested twice within 24 h; the correlation coefficient was 0.8685, indicating good repeatability. It was, therefore, concluded that the modified questionnaire was suitable for clinical study.
OUTCOMES OF QOL TESTS IN PATIENTS
For patients with brain tumours, each index was significantly lower than the controls (P = 0.049 or less; Table 2 ). Component analysis was used to measure the weighted value of all items and, based on this, an overall score of QoL was calculated. The overall QoL score in patients with brain tumours was significantly lower than normal controls (P < 0.0001).
All 431 brain tumour patients underwent surgical resection. After surgery, all indices except for psychological function were 
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significantly improved compared to preoperative data (P < 0.010 -P < 0.001; Table  3 ) and the overall pre-and post-operative QoL scores were also significantly different (P < 0.001; Table 3 ). The threshold for QoL satisfaction that represented a clinically acceptable level of patient satisfaction was set at a QoL score of 70 based on the working curve for surgery-related QoL. The sensitivity and specificity of the modified questionnaire used to assess QoL in both patients and the controls were measured at 10-point QoL score intervals (Table 4 ). A ROC curve was compiled from the logistic regression results (Fig. 1) . A QoL score of 70 gave a sensitivity of 80.1% and specificity of 71.2%.
Discussion
Since the 1990s, more attention has been paid to patients' assessment of QoL after surgery. Various generic scales exist, e.g. the Sickness Impact Profile (SIP) 20 which is a 136item scale assessing functional capabilities following illness and disease, the Medical Outcomes Survey SF-36 21 which is a 36-item measure of functional status related to health, or the EuroQoL 22 which is designed to be used in the economic evaluation of healthcare interventions. Little literature can be found, however, on the QoL of patients with brain tumours and on neurosurgical patients in general. 23 -25 Apart from KPS, 26 many non-Chinese QoL questionnaires have been used in China; however cultural differences have not been taken into consideration and this has raised concern that there may be uncertainty due to cultural bias. Li et al. 27 researched the Chinese version of the Medical Outcomes Survey SF-36 and found the means of items 28 found the Chinese interpretation of irritable bowel syndrome QoL needed to be culturally adapted and revised to possess good reliability. As a result, in order to eliminate cultural bias for Chinese patients with brain tumours, a modified QoL questionnaire was used in this study based on the KPS and the Medical Outcomes Survey SF-36. Testing of this questionnaire showed it to have good reliability and validity, and to have potential for clinical use. The QoL in post-surgical patients with brain tumours is reduced compared with normal controls however, using the working curve of surgery-related QoL, a QoL score of ≥ 70 on the modified QoL questionnaire was found to represent a clinically acceptable level of patient satisfaction.
In the last decade, brain tumour surgery has led to a substantial improvement in the mortality rate as well as in the preservation of brain function. 29, 30 For most brain tumours, surgeons strive for a satisfactory QoL in patients through the use of minimally invasive neurosurgery. 31 In the present study, physiological functions, satisfaction with medical care and self-care ability of the patients after surgery were shown to be significantly improved compared with the pre-operative status (P < 0.001), however, psychological scores were not significantly improved. This may be partially explained by the age at which most brain tumours manifest in patients. Patients with brain tumours are usually in their middle age, the time of their peak earning capacity, and the time when society and family needs are greatest. In addition, after surgery, they are often overwhelmed by feelings of despair and worry over possible recurrence. It appears, therefore, that postoperative psychological problems appear to affect global and daily QoL much more than previously thought. This serves as a reminder to medical workers that, during clinical treatment and post-operative rehabilitation, the input of a clinical psychologist may be very helpful.
The data obtained in the present study also suggest some future research possibilities. Since this study confirms that the assessment of QoL in patients with brain tumours is important and yields valid results, hopefully, in the future, QoL will be considered an important variable in the evaluation of new operative treatments. In addition, it is hoped that standardized QoL assessment will be routinely incorporated into future therapeutic cancer trials. QoL research can also be used to optimize treatment and to give important information for decision making, if treatment strategies with similar survival rates are compared.
In conclusion, this study has outlined the design of a suitable QoL questionnaire for patients with brain tumours and the tools to certify its validity and reliability. Prospective studies of larger samples of patients with brain tumours undergoing active operative treatment are necessary. Finally, future assessments might allow detailed analysis of the course of disease, as well as more detailed comparisons of different oncological groups.
